Psychiatry News

Prenatal cannabis may be linked to multiple adverse maternal health outcomes, study results published in JAMA Internal Medicine suggest.

More women and providers in both psychiatry and obstetrics and gynecology are becoming aware of the high prevalence of postpartum depression and treatments available, including recently approved zuranolone.

Increased social isolation may be linked to greater risks for several adverse health outcomes in older adults, according to a study published in JAMA Network Open.

Frequent use of touch-screen tablet games by toddlers may inhibit crucial interactions with their parents, according to preliminary research published in JAMA Network Open.

Individuals who develop type 1 diabetes during childhood experienced greater risk for several mental health conditions later in life, including anxiety disorders and substance use disorders, study results showed.

Autism spectrum disorder incidence was higher for children with prenatal exposure to antiseizure medications vs. the general population, but some associations weakened after adjusting for treatment indication, researchers reported.

Johnson & Johnson announced that it has submitted a supplemental new drug application for the approval of esketamine nasal spray as a monotherapy for adults with treatment-resistant depression.

Anxiety and depression medication use rose significantly among women in the 5 years after out-of-hospital cardiac arrest, according to a real-world study published in Circulation: Cardiovascular Quality and Outcomes.

Most physicians who are reluctant to treat addiction cited poor training and other institutional factors as major reasons for their hesitancy, a systematic review in JAMA Network Open showed.

Mushroom-containing nootropic gummies sold at gas stations and smoke shops in Virginia contained unlabeled psilocybin and psilocin, according to results of an investigation published in Morbidity and Mortality Weekly Report.